News

Published on 8 Nov 2023 on Insider Monkey via Yahoo Finance

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript

Article preview image

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript November 7, 2023

Mersana Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.31.

Operator: Good morning, and welcome to the Mersana Therapeutics Third Quarter 2023 Conference Call and Webcast. [Operator Instructions]. Please note, this call is being recorded. I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please go ahead.

Read the rest of the article
NASDAQ.MRSN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Earnings call: Mersana Therapeutics reports on ADC development progress

Mersana Therapeutics, Inc. (NASDAQ: NASDAQ: MRSN ) has provided updates on its antibody-drug...

Investing.com 1 Mar 2024
Earnings call: Mersana Therapeutics reports on ADC development progress By Investing.com

Mersana Therapeutics, Inc. (NASDAQ: NASDAQ:MRSN) has provided updates on its antibody-drug...

Investing.com 29 Feb 2024
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript February 28, 2024 Mersa...

Insider Monkey via Yahoo Finance 29 Feb 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday’s...

Shares of Butterfly Network, Inc. BFLY fell sharply during Thursday’s session after the company...

Benzinga 29 Feb 2024
An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued

Key Insights Mersana Therapeutics' estimated fair value is US$6.60 based on 2 Stage Free Cash Flo...

Simply Wall St. via Yahoo Finance 29 Feb 2024
Mersana shares climb as BTIG upgrades to buy with $6 target

Mersana shares climb as BTIG upgrades to buy with $6 target

Investing.com 28 Feb 2024
Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results

Financial Position: Mersana ended the year with $209.1 million in cash, cash equivalents, and mar...

GuruFocus.com via Yahoo Finance 28 Feb 2024
Mersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Mersana Therape...

Zacks via Yahoo Finance 20 Feb 2024
The past three years for Mersana Therapeutics (NASDAQ:MRSN) investors has not been profitable

It is a pleasure to report that the Mersana Therapeutics, Inc. (NASDAQ:MRSN) is up 83% in the las...

Simply Wall St. via Yahoo Finance 2 Jan 2024
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript November 7, 2023 Mersan...

Insider Monkey via Yahoo Finance 8 Nov 2023

Copyright Statfolio @ 2024

Social Accounts